We identified four studies that assessed the CE of CRP-POCT for antibiotic prescribing in patients with lower respiratory tract infections, reporting similarly small cost and quality of life differences between groups.26, 29 While these studies were conducted in different patient populations and settings, the similarities in the direction and magnitude of results confirm the robustness and accuracy of the CE evidence presented here. Here, CRP is linked to Recurrent lower respiratory tract infections.